127 related articles for article (PubMed ID: 37683105)
41. Cause-aware failure detection using an interpretable XGBoost for optical networks.
Zhang C; Wang D; Wang L; Guan L; Yang H; Zhang Z; Chen X; Zhang M
Opt Express; 2021 Sep; 29(20):31974-31992. PubMed ID: 34615278
[TBL] [Abstract][Full Text] [Related]
42. Deep exploration of random forest model boosts the interpretability of machine learning studies of complicated immune responses and lung burden of nanoparticles.
Yu F; Wei C; Deng P; Peng T; Hu X
Sci Adv; 2021 May; 7(22):. PubMed ID: 34039604
[TBL] [Abstract][Full Text] [Related]
43. Analysis of the in vitro nanoparticle-cell interactions via a smoothing-splines mixed-effects model.
Dogruoz E; Dayanik S; Budak G; Sabuncuoglu I
Artif Cells Nanomed Biotechnol; 2016 May; 44(3):800-10. PubMed ID: 25962529
[TBL] [Abstract][Full Text] [Related]
44. Interpretable machine learning for 28-day all-cause in-hospital mortality prediction in critically ill patients with heart failure combined with hypertension: A retrospective cohort study based on medical information mart for intensive care database-IV and eICU databases.
Peng S; Huang J; Liu X; Deng J; Sun C; Tang J; Chen H; Cao W; Wang W; Duan X; Luo X; Peng S
Front Cardiovasc Med; 2022; 9():994359. PubMed ID: 36312291
[TBL] [Abstract][Full Text] [Related]
45. Insights into colloidal nanoparticle-protein corona interactions for nanomedicine applications.
Martínez-Negro M; González-Rubio G; Aicart E; Landfester K; Guerrero-Martínez A; Junquera E
Adv Colloid Interface Sci; 2021 Mar; 289():102366. PubMed ID: 33540289
[TBL] [Abstract][Full Text] [Related]
46. Massively parallel pooled screening reveals genomic determinants of nanoparticle delivery.
Boehnke N; Straehla JP; Safford HC; Kocak M; Rees MG; Ronan M; Rosenberg D; Adelmann CH; Chivukula RR; Nabar N; Berger AG; Lamson NG; Cheah JH; Li H; Roth JA; Koehler AN; Hammond PT
Science; 2022 Jul; 377(6604):eabm5551. PubMed ID: 35862544
[TBL] [Abstract][Full Text] [Related]
47. Concentration-dependent protein adsorption at the nano-bio interfaces of polymeric nanoparticles and serum proteins.
Zhang TX; Zhu GY; Lu BY; Zhang CL; Peng Q
Nanomedicine (Lond); 2017 Nov; 12(22):2757-2769. PubMed ID: 29017387
[TBL] [Abstract][Full Text] [Related]
48. Toxicological assessment of nanoparticle interactions with the pulmonary system.
Osman NM; Sexton DW; Saleem IY
Nanotoxicology; 2020 Feb; 14(1):21-58. PubMed ID: 31502904
[TBL] [Abstract][Full Text] [Related]
49. Interpretable Machine Learning Model Predicting Early Neurological Deterioration in Ischemic Stroke Patients Treated with Mechanical Thrombectomy: A Retrospective Study.
Yang T; Hu Y; Pan X; Lou S; Zou J; Deng Q; Zhang Q; Zhou J; Zhu J
Brain Sci; 2023 Mar; 13(4):. PubMed ID: 37190522
[TBL] [Abstract][Full Text] [Related]
50. CVD22: Explainable artificial intelligence determination of the relationship of troponin to D-Dimer, mortality, and CK-MB in COVID-19 patients.
Kırboğa KK; Küçüksille EU; Naldan ME; Işık M; Gülcü O; Aksakal E
Comput Methods Programs Biomed; 2023 May; 233():107492. PubMed ID: 36965300
[TBL] [Abstract][Full Text] [Related]
51. Folate-receptor-targeted laser-activable poly(lactide-
Liu F; Chen Y; Li Y; Guo Y; Cao Y; Li P; Wang Z; Gong Y; Ran H
Int J Nanomedicine; 2018; 13():5139-5158. PubMed ID: 30233177
[TBL] [Abstract][Full Text] [Related]
52. Impact of Nanoparticle Physicochemical Properties on Protein Corona and Macrophage Polarization.
Xiao B; Liu Y; Chandrasiri I; Overby C; Benoit DSW
ACS Appl Mater Interfaces; 2023 Mar; ():. PubMed ID: 36916683
[TBL] [Abstract][Full Text] [Related]
53. Development and Interpretation of Multiple Machine Learning Models for Predicting Postoperative Delayed Remission of Acromegaly Patients During Long-Term Follow-Up.
Dai C; Fan Y; Li Y; Bao X; Li Y; Su M; Yao Y; Deng K; Xing B; Feng F; Feng M; Wang R
Front Endocrinol (Lausanne); 2020; 11():643. PubMed ID: 33042013
[No Abstract] [Full Text] [Related]
54. Arginine-based poly(ester amide) nanoparticle platform: From structure-property relationship to nucleic acid delivery.
You X; Gu Z; Huang J; Kang Y; Chu CC; Wu J
Acta Biomater; 2018 Jul; 74():180-191. PubMed ID: 29803783
[TBL] [Abstract][Full Text] [Related]
55. Do we need different machine learning algorithms for QSAR modeling? A comprehensive assessment of 16 machine learning algorithms on 14 QSAR data sets.
Wu Z; Zhu M; Kang Y; Leung EL; Lei T; Shen C; Jiang D; Wang Z; Cao D; Hou T
Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33313673
[TBL] [Abstract][Full Text] [Related]
56. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform.
Hou L; Shan X; Hao L; Feng Q; Zhang Z
Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767
[TBL] [Abstract][Full Text] [Related]
57. Investigating the Effect of Aging on the Pharmacokinetics and Tumor Delivery of Nanomaterials using Mathematical Modeling.
Dogra P; Butner JD; Ramirez JR; Cristini V; Wang Z
Annu Int Conf IEEE Eng Med Biol Soc; 2020 Jul; 2020():2447-2450. PubMed ID: 33018501
[TBL] [Abstract][Full Text] [Related]
58. Control of polymeric nanoparticle size to improve therapeutic delivery.
Hickey JW; Santos JL; Williford JM; Mao HQ
J Control Release; 2015 Dec; 219():536-547. PubMed ID: 26450667
[TBL] [Abstract][Full Text] [Related]
59. Explainable machine learning approach to predict extubation in critically ill ventilated patients: a retrospective study in central Taiwan.
Pai KC; Su SA; Chan MC; Wu CL; Chao WC
BMC Anesthesiol; 2022 Nov; 22(1):351. PubMed ID: 36376785
[TBL] [Abstract][Full Text] [Related]
60. Therapeutic Fluorescent Hybrid Nanoparticles for Traceable Delivery of Glucocorticoids to Inflammatory Sites.
Napp J; Markus MA; Heck JG; Dullin C; Möbius W; Gorpas D; Feldmann C; Alves F
Theranostics; 2018; 8(22):6367-6383. PubMed ID: 30613305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
